Our data suggest that cardiac NPs, via GC-A/cGMP signaling, support these pathways and thereby the adaptative proliferation of β-cells during early stages of obesity-linked insulin resistance and metabolic syndrome. The gene discussed is GCA; the disease is metabolic syndrome.